François Verrière

466 total citations
20 papers, 321 citations indexed

About

François Verrière is a scholar working on Surgery, Dermatology and Epidemiology. According to data from OpenAlex, François Verrière has authored 20 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Dermatology and 5 papers in Epidemiology. Recurrent topics in François Verrière's work include Reproductive tract infections research (4 papers), Skin Protection and Aging (4 papers) and Cervical Cancer and HPV Research (3 papers). François Verrière is often cited by papers focused on Reproductive tract infections research (4 papers), Skin Protection and Aging (4 papers) and Cervical Cancer and HPV Research (3 papers). François Verrière collaborates with scholars based in France, United Kingdom and Canada. François Verrière's co-authors include Thérèse Nocera, H Schneid, Nicholas Moore, Éric Van Ganse, C. Taïeb, E Myon, Ronald Wall, L. Misery, Brigitte Dréno and S Boisnic and has published in prestigious journals such as Value in Health, Pharmacoepidemiology and Drug Safety and Dermatology.

In The Last Decade

François Verrière

19 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Verrière France 11 121 78 46 33 32 20 321
Mitchell R. Lester United States 9 171 1.4× 57 0.7× 77 1.7× 16 0.5× 6 0.2× 39 673
Orapan Poachanukoon Thailand 13 38 0.3× 31 0.4× 54 1.2× 28 0.8× 5 0.2× 42 361
J. Cuesta Spain 11 223 1.8× 255 3.3× 36 0.8× 17 0.5× 11 0.3× 28 544
Mercedes E. Arroliga United States 9 111 0.9× 249 3.2× 31 0.7× 20 0.6× 8 0.3× 13 424
Lovely Gupta India 12 13 0.1× 39 0.5× 33 0.7× 69 2.1× 6 0.2× 41 408
Hee Youn Kim South Korea 14 6 0.0× 32 0.4× 77 1.7× 86 2.6× 23 0.7× 47 451
G. Menke Germany 11 50 0.4× 46 0.6× 67 1.5× 31 0.9× 1 0.0× 33 472
H. Scheijgrond Belgium 7 12 0.1× 35 0.4× 36 0.8× 112 3.4× 8 0.3× 11 318
J. Hale Australia 13 97 0.8× 11 0.1× 19 0.4× 63 1.9× 6 0.2× 14 593
J Igea Spain 14 212 1.8× 112 1.4× 49 1.1× 22 0.7× 3 0.1× 26 544

Countries citing papers authored by François Verrière

Since Specialization
Citations

This map shows the geographic impact of François Verrière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Verrière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Verrière more than expected).

Fields of papers citing papers by François Verrière

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Verrière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Verrière. The network helps show where François Verrière may publish in the future.

Co-authorship network of co-authors of François Verrière

This figure shows the co-authorship network connecting the top 25 collaborators of François Verrière. A scholar is included among the top collaborators of François Verrière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Verrière. François Verrière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serfaty, D., V N Prilepskaya, Olivier Graesslin, et al.. (2023). Efficacy, safety and acceptability of a benzalkonium chloride spermicide cream in women aged 40 years and over needing contraception: A prospective multicentre study. Journal of Gynecology Obstetrics and Human Reproduction. 52(7). 102616–102616.
2.
Sousa, Ana Paula, et al.. (2021). Comparative in vitro study on the local tolerance and efficacy of benzalkonium chloride, myristalkonium chloride and nonoxynol-9 as active principles in vaginal contraceptives. The European Journal of Contraception & Reproductive Health Care. 26(4). 334–342. 2 indexed citations
3.
Nunes, Carlos Pereira, et al.. (2020). Is Nonmicronized Diosmin 600 mg as Effective as Micronized Diosmin 900 mg plus Hesperidin 100 mg on Chronic Venous Disease Symptoms? Results of a Noninferiority Study. International Journal of Vascular Medicine. 2020. 1–9. 14 indexed citations
4.
Galanaud, J.‐P., et al.. (2020). Compression stockings to prevent postthrombotic syndrome: Literature overview and presentation of the CELEST trial. Research and Practice in Thrombosis and Haemostasis. 4(8). 1239–1250. 4 indexed citations
5.
Bohbot, J.-M., et al.. (2019). PRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitis. Médecine et Maladies Infectieuses. 49(3). 194–201. 6 indexed citations
6.
Boisnic, S, et al.. (2018). Anti‐inflammatory and antiradical effects of a 2% diosmin cream in a human skin organ culture as model. Journal of Cosmetic Dermatology. 17(5). 848–854. 16 indexed citations
7.
Neut, Christel, François Verrière, Hans J. Nelis, & Tom Coenye. (2015). Topical Treatment of Infectious Vaginitis: Effects of Antibiotic, Antifungal and Antiseptic Drugs on the Growth of Normal Vaginal <i>Lactobacillus</i> Strains. Open Journal of Obstetrics and Gynecology. 5(3). 173–180. 9 indexed citations
8.
Verrière, François, et al.. (2015). Bactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?. Médecine et Maladies Infectieuses. 45(3). 89–94. 8 indexed citations
9.
Sednaoui, Patrice, et al.. (2014). Nystatin-Neomycin-Polymyxin B Combination: Efficacy and Tolerance as 1st-Line Local Treatment of Infectious Vaginitis. Open Journal of Obstetrics and Gynecology. 4(7). 445–454. 6 indexed citations
10.
Bohbot, J.-M., et al.. (2011). Diversité étiologique des vaginites. Gynécologie Obstétrique & Fertilité. 40(10). 578–581. 13 indexed citations
11.
Boisnic, S, et al.. (2005). RALGA (Diacnéal<sup>®</sup>) Decreases Melanin Content in a Human Skin Model. Dermatology. 210(Suppl. 1). 35–38. 9 indexed citations
12.
Misery, L., et al.. (2005). Peaux sensibles en France : approche épidémiologique. Annales de Dermatologie et de Vénéréologie. 132(5). 425–429. 62 indexed citations
13.
Dréno, Brigitte, et al.. (2005). Topical Retinaldehyde with Glycolic Acid: Study of Tolerance and Acceptability in Association with Anti-Acne Treatments in 1,709 Patients. Dermatology. 210(Suppl. 1). 22–29. 13 indexed citations
14.
Mordon, Serge, et al.. (2004). Ultrasound imaging demonstration of the improvement of non‐ablative laser remodeling by concomitant daily topical application of 0.05% retinaldehyde. Journal of Cosmetic and Laser Therapy. 6(1). 5–9. 10 indexed citations
15.
Dréno, Brigitte, A.Y. Finlay, Thérèse Nocera, et al.. (2004). The Cardiff Acne Disability Index: Cultural and Linguistic Validation in French. Dermatology. 208(2). 104–108. 23 indexed citations
16.
Misery, L., E Myon, Nicolas Martin, et al.. (2004). PES19 SENSITIVE SKIN: QUALITY OF LIFE IMPACT. Value in Health. 7(6). 751–751. 1 indexed citations
17.
Moore, Nicholas, Andrew Charlesworth, Éric Van Ganse, et al.. (2003). Risk factors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiology and Drug Safety. 12(7). 601–610. 41 indexed citations
18.
19.
Rampal, Patrick, Nicholas Moore, Éric Van Ganse, et al.. (2002). Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-Counter Doses. Journal of International Medical Research. 30(3). 301–308. 34 indexed citations
20.
Boureau, F., et al.. (1999). Evaluation of Ibuprofen vs Paracetamol Analgesic Activity Using a Sore Throat Pain Model. Clinical Drug Investigation. 17(1). 1–8. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitchell R. Lester Breakdown of academic impact, for papers by Orapan Poachanukoon Breakdown of academic impact, for papers by J. Cuesta Breakdown of academic impact, for papers by Mercedes E. Arroliga Breakdown of academic impact, for papers by Lovely Gupta Breakdown of academic impact, for papers by Hee Youn Kim Breakdown of academic impact, for papers by G. Menke Breakdown of academic impact, for papers by H. Scheijgrond Breakdown of academic impact, for papers by J. Hale Breakdown of academic impact, for papers by J Igea
Rankless by CCL
2026